Vestal Point Capital’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$85.8M Buy
375,000
+200,000
+114% +$44.8M 2.4% 11
2025
Q4
$37.3M Sell
175,000
-425,000
-71% -$87.8M 1.37% 26
2025
Q3
$119M Buy
600,000
+400,000
+200% +$74.6M 5.41% 1
2025
Q2
$34.5M Buy
200,000
+49,858
+33% +$8.12M 1.82% 19
2025
Q1
$23.4M Sell
150,142
-369,858
-71% -$52.8M 1.67% 21
2024
Q4
$71.6M Buy
520,000
+270,000
+108% +$35.5M 4.24% 4
2024
Q3
$37.3M Sell
250,000
-500,000
-67% -$67.5M 2.95% 11
2024
Q2
$102M Buy
750,000
+225,000
+43% +$30.6M 7.63% 3
2024
Q1
$79.4M Sell
525,000
-100,000
-16% -$14.3M 6.56% 4
2023
Q4
$78.7M Buy
+625,000
New +$62.3M 8.34% 3

Other funds holding ASND